Equities

3-D Matrix Ltd

7777:TYO

3-D Matrix Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)119.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.07m
  • 1 Year change-22.22%
  • Beta1.0891
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year 3-D Matrix Ltd grew revenues 98.30% from 2.31bn to 4.59bn while net income improved from a loss of 2.45bn to a smaller loss of 255.50m.
Gross margin68.38%
Net profit margin-20.04%
Operating margin-37.33%
Return on assets-17.15%
Return on equity-173.26%
Return on investment-21.31%
More ▼

Cash flow in JPYView more

In 2024, 3-D Matrix Ltd increased its cash reserves by 16.45%, or 192.64m. Cash Flow from Financing totalled 2.06bn or 44.95% of revenues. In addition the company used 1.90bn for operations while cash used for investing totalled 29.76m.
Cash flow per share-10.04
Price/Cash flow per share--
Book value per share11.66
Tangible book value per share11.66
More ▼

Balance sheet in JPYView more

3-D Matrix Ltd has a Debt to Total Capital ratio of 79.79%, a lower figure than the previous year's 2,891.11%.
Current ratio4.88
Quick ratio2.51
Total debt/total equity3.95
Total debt/total capital0.7979
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.